Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Post-operative Residual Curarization × Neostigmine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urologic Neoplasms 1 Supratentorial Brain Tumor Surgery 1 Stomach Neoplasms 1 Post-operative Residual Curarization 1 Myasthenia Gravis 1 Delayed Emergence from Anesthesia 1 Breast Neoplasms 1

Interventions

Sugammadex 1 Neostigmine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03996655 2019-06-25

Different Reversal Agents in Pediatric Day-case Cancer Surgery

National Cancer Institute, Egypt

Phase 4 Unknown

Post-operative Residual Curarization

Data powered by HemOnc (CC BY 4.0) Colophon ⚡